من 1 من التقييمات خلال آخر 6 أشهر. هذه ليست توصية استثمارية.
شراء
0%
متوقف
100%
بيع
0%
حول
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.